Cognetivity Neurosciences Ltd. (CGNSF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 30, 2025
Cognetivity Neurosciences Company Description
Cognetivity Neurosciences Ltd. operates as a technology company.
It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app.
The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017.
Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Cognetivity Neurosciences Ltd.
| Country | Canada |
| Founded | 2015 |
| Industry | Health Information Services |
| Sector | Healthcare |
| CEO | Sina Habibi |
Contact Details
Address: 1055 West Hastings Street Vancouver, BC V6E 2E9 Canada | |
| Website | cognetivity.com |
Stock Details
| Ticker Symbol | CGNSF |
| Exchange | OTCMKTS |
| Fiscal Year | February - January |
| Reporting Currency | CAD |
| ISIN Number | CA19243C1005 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Sina Habibi | Co-Founder, Chief Executive Officer and Director |
| Dr. Seyed-Mahdi Khaligh-Razavi | Co-Founder and CIO |
| Dr. Thomas Roger Sawyer M.B.A., Ph.D. | Chief Financial Officer, Company Secretary and Director |
| Desmond M. Balakrishnan B.A., L.L.B. | Legal Counsel and Director |